Keryx options active on wide price movement Keryx February 8 and March 9 calls are active on total call volume of 14K contracts (10K puts). February call option implied volatility is at of 127, March is at 100; compared to its 26-week average of 110 according to Track Data, Active option volume suggests traders taking positions for larger price movement.
Keryx survey results positive, says Oppenheimer After surveying 50 nephrologists/nurses/dietitians at U.S. dialysis clinics, Oppenheimer reported that dialysis providers it surveyed expect to prescribe Keryx's Auryxia in 11% of new starts and about 12% of switchers . As a result of this data points and other data from the survey, the firm expects Auryxia prescription trends to improve. It keeps an $18 price target and Outperform rating on the shares.